2Seventy Current Deferred Revenue from 2010 to 2024
| TSVT Stock | USD 3.99 0.03 0.76% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 15.4 M | Current Value 16.2 M | Quarterly Volatility 3.9 M |
Check 2Seventy Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 2Seventy Bio's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 10.8 M or Depreciation And Amortization of 10.7 M, as well as many indicators such as Price To Sales Ratio of 1.99, Dividend Yield of 0.0 or PTB Ratio of 0.78. 2Seventy financial statements analysis is a perfect complement when working with 2Seventy Bio Valuation or Volatility modules.
2Seventy | Current Deferred Revenue |
Latest 2Seventy Bio's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of 2Seventy Bio over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. 2Seventy Bio's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 2Seventy Bio's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
2Seventy Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 8,342,410 | |
| Geometric Mean | 7,098,163 | |
| Coefficient Of Variation | 46.16 | |
| Mean Deviation | 2,160,964 | |
| Median | 8,474,000 | |
| Standard Deviation | 3,851,208 | |
| Sample Variance | 14.8T | |
| Range | 15.4M | |
| R-Value | 0.13 | |
| Mean Square Error | 15.7T | |
| R-Squared | 0.02 | |
| Significance | 0.65 | |
| Slope | 111,572 | |
| Total Sum of Squares | 207.6T |
2Seventy Current Deferred Revenue History
About 2Seventy Bio Financial Statements
2Seventy Bio shareholders use historical fundamental indicators, such as Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although 2Seventy Bio investors may analyze each financial statement separately, they are all interrelated. The changes in 2Seventy Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on 2Seventy Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 15.4 M | 16.2 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for 2Seventy Stock Analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.